Speaker illustration

Associate Professor Arrigo Francesco Giuseppe Cicero

Alma Mater Studiorum, University of Bologna, Bologna (Italy)

Arrigo F.G. Cicero, MD, PhD, Board qualified in Clinical Pharmacology, Associate Professor of Human Nutrition by the University of Bologna, President of the Italian Nutraceutical Society (SINut), Member of the Board currently involved in different Clinical researches (Mono- and multi-centre clinical trials on dietary supplements and drugs) and epidemiological studies (mainly, the Brisighella Heart Study and its sub-studies), he is author of Author of more than 500 full scientific papers published on international press (among which 470 on Pub-Med, total 2020 IF>1900, Scopus h-index= 57), 12 full books, 20 chapters in national and international books, 21 full papers published on national and international congress proceedings, mainly in the fields of diet, dietary supplements, and preventive medicine. He is also member of the editorial board of Nutrients, JCM, Disease, High Blood Press Cardiovasc Dis. Frontiers Clin Diab and other international peer reviewed journals.

Is there ‘good’ and ‘bad’ food for the heart?: Position 2

Event: ESC Preventive Cardiology 2022

Topic: European Association of Preventive Cardiology (EAPC)

Session: Food for your heart: personalised nutrition for cardiovascular prevention

Thumbnail

Long-term impact of different triple antihypertensive drug treatments on blood pressure control, metabolic pattern and incident events: data from the Brisighella Heart Study

Event: ESC Preventive Cardiology 2022

Topic: Pharmacotherapy

Session: ePosters

Thumbnail

Representativeness of women and racial/ethnic minorities in randomized clinical trials on bempedoic acid

Event: ESC Preventive Cardiology 2022

Topic: Lipids

Session: ePosters

Thumbnail

Non-invasive instrumental evaluation of coenzyme Q10 phytosome on endothelial reactivity in healthy non-smoking young volunteers: a double-blind, placebo-controlled cross-over clinical trial

Event: ESC Preventive Cardiology 2022

Topic: Lifestyle Modification

Session: ePosters

Thumbnail

Low risk obese patient with persistently elevated mean LDL-C =141 mg/dl, who is not willing to use statins. To treat or not to treat?

Event: ESC Preventive Cardiology 2021

Topic: Risk Factors and Prevention

Session: Clinical cases session - Primary care and risk factor management

Thumbnail

ESC 365 is supported by

logo Novo Nordisk